112 related articles for article (PubMed ID: 14652279)
1. A prospective study of plasma total cysteine and risk of breast cancer.
Zhang SM; Willett WC; Selhub J; Manson JE; Colditz GA; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1188-93. PubMed ID: 14652279
[TBL] [Abstract][Full Text] [Related]
2. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
3. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
4. A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer.
Wu K; Helzlsouer KJ; Comstock GW; Hoffman SC; Nadeau MR; Selhub J
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):209-17. PubMed ID: 10090298
[TBL] [Abstract][Full Text] [Related]
5. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk.
Han J; Hankinson SE; Zhang SM; De Vivo I; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):520-4. PubMed ID: 15066914
[TBL] [Abstract][Full Text] [Related]
6. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
Page JH; Colditz GA; Rifai N; Barbieri RL; Willett WC; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1032-6. PubMed ID: 15184260
[TBL] [Abstract][Full Text] [Related]
7. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
8. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.
Wei EK; Giovannucci E; Selhub J; Fuchs CS; Hankinson SE; Ma J
J Natl Cancer Inst; 2005 May; 97(9):684-92. PubMed ID: 15870439
[TBL] [Abstract][Full Text] [Related]
9. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
[TBL] [Abstract][Full Text] [Related]
10. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
12. Plasma cysteinylglycine levels and breast cancer risk in women.
Lin J; Manson JE; Selhub J; Buring JE; Zhang SM
Cancer Res; 2007 Dec; 67(23):11123-7. PubMed ID: 18056435
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
14. Plasma organochlorine levels and subsequent risk of breast cancer among Japanese women: a nested case-control study.
Iwasaki M; Inoue M; Sasazuki S; Kurahashi N; Itoh H; Usuda M; Tsugane S;
Sci Total Environ; 2008 Sep; 402(2-3):176-83. PubMed ID: 18555519
[TBL] [Abstract][Full Text] [Related]
15. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
16. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
17. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
[TBL] [Abstract][Full Text] [Related]
18. Plasma carotenoids, retinol, and tocopherols and risk of breast cancer.
Tamimi RM; Hankinson SE; Campos H; Spiegelman D; Zhang S; Colditz GA; Willett WC; Hunter DJ
Am J Epidemiol; 2005 Jan; 161(2):153-60. PubMed ID: 15632265
[TBL] [Abstract][Full Text] [Related]
19. Urinary melatonin levels and breast cancer risk.
Schernhammer ES; Hankinson SE
J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307
[TBL] [Abstract][Full Text] [Related]
20. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group.
Iwasaki M; Inoue M; Otani T; Sasazuki S; Kurahashi N; Miura T; Yamamoto S; Tsugane S;
J Clin Oncol; 2008 Apr; 26(10):1677-83. PubMed ID: 18316793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
